Zen Koh Appointed Strategic Industry Advisor and Entrepreneur-in-Residence at KITE

With over two decades in the healthcare, rehabilitation technology, and robotics industries, Zen Koh brings a wealth of experience to these roles.

Toronto, Canada – December 20, 2024—The KITE Research Institute at the Toronto Rehabilitation Institute, part of the University Health Network (UHN), is pleased to announce Zen Koh's appointment as its new Strategic Industry Advisor and Entrepreneur-in-Residence (EIR). With over two decades of active involvement in the healthcare, rehabilitation technology, and robotics industries, Zen Koh brings an unparalleled wealth of experience to these key roles.

As Strategic Industry Advisor, Koh will play a crucial role in advancing KITE’s commercialization strategy. His expertise will be instrumental in connecting KITE’s cutting-edge research and technologies with industry partners globally. Koh will foster new collaborations, secure funding opportunities, and promote KITE’s research, amplifying the Institute’s impact in the global rehabilitation technology sector. With his extensive experience driving business growth and innovation, particularly in healthcare and rehabilitation technologies, Koh is uniquely positioned to help propel KITE to new heights.

In his role as Entrepreneur-in-Residence, Koh will provide invaluable mentorship to KITE’s scientific community, offering guidance on the commercialization of emerging technologies. By bridging the gap between research breakthroughs and their practical applications in clinical settings, Koh’s insight will help accelerate the translation of KITE’s innovations into real-world solutions that significantly enhance patient care and outcomes.

Zen Koh is the CEO of NovaKonexus Inc., a cutting-edge spin-off from UHN dedicated to advancing neurorehabilitation technologies. He is also the President and Ambassador of the International Industry Society for Advanced Rehabilitation Technology (IISART), a global organization that drives the advancement of rehabilitation technology through international collaboration. In addition, Koh is the Founder and Executive Director of MotusAcademy, an educational initiative focused on fostering innovation and excellence in the rehabilitation technology field. Koh has also served as an advisor to leading rehabilitation and robotics companies worldwide and has been instrumental in securing mainstream investments from major entities such as Saudi Aramco Venture’s Prosperity7 and Softbank.

"I am deeply honoured to join the KITE team," said Zen Koh. "The groundbreaking research and innovations at KITE are setting new standards in rehabilitation technology, and I am excited to contribute to the Institute’s mission of transforming patient care globally. I look forward to collaborating with KITE’s exceptional researchers and industry partners to help bring these life-changing innovations to the world."

Koh’s appointment marks a significant step forward in KITE’s ongoing mission to drive the commercialization of transformative rehabilitation technologies. With his leadership, KITE aims to strengthen its global position as a leader in rehabilitation research and accelerate the development of solutions that improve the quality of life for individuals with complex healthcare needs.

About Zen Koh
Zen Koh has been a driving force in the healthcare and rehabilitation technology industry for more than 20 years. As CEO of NovaKonexus, he is dedicated to advancing neurorehabilitation technologies and fostering collaboration between industry leaders, researchers, and healthcare providers. Koh is also the President and Ambassador of IISART (International Industry Society for Advanced Rehabilitation Technology), a platform dedicated to global collaboration and the advancement of rehabilitation technology. As the Founder and Executive Director of MotusAcademy, Koh is committed to nurturing the next generation of leaders in rehabilitation technology. His advisory roles with leading AI-driven robotics and rehabilitation companies further highlight his expertise and dedication to improving patient care.